BOT 1.47% 33.5¢ botanix pharmaceuticals ltd

Ann: BTX 1503 End of Phase 2 Milestone with FDA, page-11

  1. 60 Posts.
    lightbulb Created with Sketch. 5
    So Phase 3 is going to be similar to phase 2 that the primary endpoints need to be successful ?

    1. Absolute change from baseline in inflammatory and absolute change from baseline in noninflammatory lesion at Week 12; and
    2. Proportion of patients with an Investigators Global Assessment (IGA) of “clear” or “almost clear” and at least a 2-grade improvement in IGA from baseline at Week 12.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.005(1.47%)
Mkt cap ! $606.3M
Open High Low Value Volume
33.5¢ 34.0¢ 33.0¢ $488.6K 1.448M

Buyers (Bids)

No. Vol. Price($)
13 533788 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 247773 13
View Market Depth
Last trade - 12.04pm 10/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.